Canada markets open in 6 hours 14 minutes

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.0800+0.0894 (+9.02%)
At close: 04:00PM EDT
1.0700 -0.01 (-0.93%)
After hours: 07:52PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 161.58M
Enterprise Value 247.55M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.08
Price/Book (mrq)63.84
Enterprise Value/Revenue 1.96
Enterprise Value/EBITDA -2.63

Trading Information

Stock Price History

Beta (5Y Monthly) 2.25
52-Week Change 3-80.18%
S&P500 52-Week Change 323.57%
52 Week High 36.2600
52 Week Low 30.5400
50-Day Moving Average 30.8408
200-Day Moving Average 31.7937

Share Statistics

Avg Vol (3 month) 34.4M
Avg Vol (10 day) 36.25M
Shares Outstanding 5151.01M
Implied Shares Outstanding 6151.01M
Float 8119.11M
% Held by Insiders 15.68%
% Held by Institutions 159.46%
Shares Short (Apr 15, 2024) 417.63M
Short Ratio (Apr 15, 2024) 44.76
Short % of Float (Apr 15, 2024) 416.36%
Short % of Shares Outstanding (Apr 15, 2024) 411.68%
Shares Short (prior month Mar 15, 2024) 418.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -90.03%
Operating Margin (ttm)-61,759.38%

Management Effectiveness

Return on Assets (ttm)-19.08%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)126.33M
Revenue Per Share (ttm)0.99
Quarterly Revenue Growth (yoy)-93.40%
Gross Profit (ttm)N/A
EBITDA -101.74M
Net Income Avi to Common (ttm)-113.72M
Diluted EPS (ttm)-0.8900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)127.97M
Total Cash Per Share (mrq)0.85
Total Debt (mrq)213.94M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.78
Book Value Per Share (mrq)-0.33

Cash Flow Statement

Operating Cash Flow (ttm)-117.35M
Levered Free Cash Flow (ttm)-56.9M